Efficacy and safety of nucleoside antiviral drugs for treatment of recurrent herpes labialis: a systematic review and meta‐analysis

  title={Efficacy and safety of nucleoside antiviral drugs for treatment of recurrent herpes labialis: a systematic review and meta‐analysis},
  author={Fangman Chen and Hao Xu and Jinli Liu and Yuan-Rong Cui and Xiaobo Luo and Yu Zhou and Qianming Chen and Lu Jiang},
  journal={Journal of Oral Pathology \& Medicine},
OBJECTIVES To evaluate the effectiveness and safety of nucleoside antiviral drugs for the treatment of recurrent herpes labialis. METHODS Randomized controlled trials that examined the effectiveness and/or safety of nucleoside antiviral drugs for recurrent herpes labialis were identified via a literature search. The parameters used to measure efficacy were time to healing of classic and all lesions, time to resolution of pain, and percentage of aborted lesions. Safety was assessed by… 

Figures and Tables from this paper

Efficacy of low-level laser therapy in management of recurrent herpes labialis: a systematic review
It is suggested that laser is potentially a safe and effective treatment alternative for the management of RHL, however, due to high variability in study designs and inconsistency in laser parameters among the included studies, more well-designed randomized clinical trials with standardized laser parameters are highly warranted.
Clinical Study on the Effectiveness of Three Products in the Treatment of Herpes Simplex Labialis
Herpatch proved to be an effective, non-antiviral alternative in the treatment of HSL, and the reaction rate and quality of therapy of Herpatch were significantly higher than those of Compeed and Zovirax.
Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2
Proton pump inhibitors increase the anti-HSV activity of acy Clovir and are candidates for antiviral therapies in combination with acyclovir, in particular for topical preparations for the treatment of immunocompromised individuals who are more likely to suffer from severe complications.
Anti-herpetic Activity of Macrocystis pyrifera and Durvillaea antarctica Algae Extracts Against HSV-1 and HSV-2
Evaluation of the algae extracts as topical formulations in an animal model of HSV-1 skin infection significantly reduced the severity of the disease more than acyclovir, as well as the duration of the herpetic lesions, when compared to mock-treated animals, with the D. antarctica extract performing best.
Pilot Study of the Safety and Tolerability of a Subconjunctival Penciclovir Implant in Cats Experimentally Infected with Herpesvirus.
  • J. Covert, S. Thomasy, D. Maggs
  • Medicine
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
  • 2019
Subconjunctival blank and penciclovir-impregnated implants were well tolerated at the ocular surface and not associated with systemic toxicity, adverse effect, or appreciable plasma pencIClovir concentrations.
Recent Developments in Infectious Disease Chemotherapy: Review for Emergency Department Practitioners 2020
New antimicrobials for treatment of bacterial, viral, fungal, and parasitic infections with indications, contraindications, and side effects for each are discussed and reviewed.
Current Antivirals and Novel Botanical Molecules Interfering With Herpes Simplex Virus Infection
Currently available anti-herpetic therapies, novel molecules being assessed in clinical trials and new botanical compounds reported in the last 20 years with antiviral activities against HSVs that might represent future treatments against these viruses are reviewed.
How effective are topical agents for the treatment of cold sores?
A higher rate of spontaneous vaginal delivery was noted among women who underwent membrane sweeping compared with non-swept women and a shorter interval between induction and onset of labor among multiparous women.


Treatment of Recurrent Herpes Simplex Labialis with Oral Acyclovir
Oral acyclovir alleviated some of the clinical manifestations of herpes simplex labialis and hastened lesion resolution among the patients who could start treatment in the prodrome or erythema lesion stage.
Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir
Topical acyclovir in polyethylene glycol was ineffective for the treatment of herpes labialis despite an optimum therapeutic opportunity.
Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group.
Penciclovir cream is the first treatment to clearly demonstrate an impact on the course of recurrent herpes simplex labialis in immunocompetent patients.
Acyclovir Cream for Treatment of Herpes Simplex Labialis: Results of Two Randomized, Double-Blind, Vehicle-Controlled, Multicenter Clinical Trials
Acyclovir cream did not prevent the development of classical lesions (progression to vesicles, ulcers, and/or crusts) and there was a statistically significant reduction in the duration of lesion pain in both studies.
Efficacy and safety of aciclovir mucoadhesive buccal tablet in immunocompetent patients with labial herpes (LIP Trial): a double-blind, placebo-controlled, self-initiated trial.
A single application of ABT improves all endpoints of HL and might modify its clinical course in decreasing the incidence and delaying the onset of the next recurrence.
A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis.
Successful treatment of herpes labialis with topical acyclovir.
First episodes and all episodes treated with acyclovir cream had significantly shorter times to formation of ulcer or crust and to complete healing (p less than 0.05 for all variables).
Topical iontophoretic administration of acyclovir for the episodic treatment of herpes labialis: a randomized, double-blind, placebo-controlled, clinic-initiated trial.
Single-dose topical iontophoresis of acyclovir appears to be a convenient and effective treatment for cold sores and merits further clinical investigation.
Topical acyclovir in the management of recurrent herpes labialis
Acyclovir ointment is well tolerated and appears to modify the course of severe recurrent herpes labialis when therapy is initiated by the patient during the prodrome.